Bladder pain (Interstitial Cystitis) is caused by a chronic inflammation of the urinary bladder. This inflammation is associated with a relative thermal hyperalgesia referred to the hind limb. Palmitoylethanolamide (Normast) attenuates this referred hyperalgesia in a dose-depended fashion. These result implicates that Palmitoylethanolamide (Normast) can be seen as a novel treatment for bladder pain.
In the US, every year more than 750.000 patients die from side effects of modern painkillers. These figures stress the need of searching for saver alternatives concerning pain management. But now, there is finally a breakthrough in save and effective chronic pain treatment. For years, patients suffering from chronic pain have been waiting for this;
A new painkiller (Palmitoylethanolamide (Normast)), virtually devoid of side effects, easy to combine with other painkillers and drugs, effective in a great number of chronic painstates has been presented this week in the international well known ‘Open Pain Journal’.
A recent study* shows that nerve damage (caused by chemotherapy) in patients with Kahler’s disease can be reversed by the natural compound Palmitoylethanolamide (Normast). These results were presented by researchers of the University of Rome and are published in the journal CNS & Neurological Disorders – Drug Targets.
